TissueLabs specializes in advanced bioprinting technologies aimed at creating tissues and organs in laboratory settings. Their offerings include a range of bioprinters, such as the TissueStart™ and TissueRay™ 3D Bioprinters, which are designed to facilitate the precise layering of cells and biomaterials to construct complex tissue structures. Additionally, TissueLabs provides MatriXpec™ hydrogels, which serve as a supportive medium for cell growth, and TissueCoat™ ECM surface coatings that enhance cell adhesion and functionality. These products are integral to researchers focused on tissue engineering, drug discovery, and regenerative medicine.

The company emphasizes the importance of creating reliable models for studying various biological processes, including the tumor microenvironment and liver physiology. Their technologies enable scaffold-free and scaffold-based bioprinting approaches, allowing for greater flexibility and innovation in tissue engineering. By providing comprehensive solutions that include both equipment and consumables, TissueLabs supports researchers in their quest to develop more effective therapies and understand complex biological systems.

Switzerland

TissueLabs makes a platform for creating tissues and organs in the lab.

TissueLabs

TissueLabs

Company Details